MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Wednesday reported a loss of $11.9 million in its third quarter.
The Montreal-based company said it had a loss of 12 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MIST at https://www.zacks.com/ap/MIST
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
